Side-by-side comparison of AI visibility scores, market position, and capabilities
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
FY2024 Revenue: 234.58B SEK (~$22.29B) (+1% local currency) | Operating Profit: 17.3B SEK, margin 7.4% | EPS +34% to SEK 7.21 | Q4 2024: 62.19B SEK ($6.15B) | 2025: Opening 80 stores (emerging markets), closing 190 | Facing competition from Zara and Shein
H&M is a multinational fast fashion retailer offering trendy, affordable clothing, accessories, and home goods for men, women, and children through both physical stores and e-commerce. The company serves fashion-conscious consumers globally who want current styles at accessible price points with frequent inventory turnover. H&M has established itself as a fast fashion leader through rapid design-to-store cycles, collaborations with luxury designers, sustainability initiatives like garment recycling programs, and a global retail footprint that makes fashionable clothing available to mainstream consumers.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.